ICU sedation, delirium & recovery

Estimated glomerular filtration rate among intensive care unit survivors: From the removal of race coefficient to cystatin C-based equations

J Crit CarePublished Retrospective cohort study

Authors' conclusion

Among ICU survivors, removal of race coefficient leads to lower eGFR in Black patients and may contribute to overestimation of kidney function in non-Black patients. While cysC is rarely used, estimates based on this marker are significantly lower than those based on sCr.

Study context

Population
Intensive care unit (ICU) survivors from 2 institutions in the Bronx and Boston; Estimated glomerular filtration rate (eGFR) at hospital discharge
Participants
30,920 survivors
Exposure
eGFR with vs without race coefficient; Cystatin C (cysC)- vs serum creatinine (sCr)-based eGFR
Outcome
eGFRsCr2021 vs eGFRsCr2009
Follow-up
Hospital discharge
Methodological detailstwo-centre
  • Two-centre

Main finding

As reported in the abstract

Median difference

4 ml/min/1.73 m²

higher among non-Black patients

Median difference

8 ml/min/1.73 m²

lower among Black patients

Non-Black subjects reclassified to better eGFR category
12.9%
Black subjects reclassified to worse eGFR category
16.1%

Observational data: associations, not effects.

Further findings

OutcomeMedian difference (ml/min/1.73 m²)
cysC- vs sCr-based eGFR (subset with available cysC: 51 patients, 108 measurements) · between ICU admission and 1-year follow-upcysC-based estimates lower9 to 16
cysC- vs sCr-based eGFR (subset with available cysC: 51 patients, 108 measurements) — Measurements reclassified to worse eGFR category
34% to 53.5%

Original publication

Estimated glomerular filtration rate among intensive care unit survivors: From the removal of race coefficient to cystatin C-based equations. J Crit Care. Published 31 October 2023. doi:10.1016/j.jcrc.2023.154450

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.